Structure of melanoma inhibitory activity protein, a member of a recently identified family of secreted proteins
- *Department of Molecular and Cell Biology, 229 Stanley Hall, University of California, Berkeley, CA 94720; and †DNAX Research Institute, 901 California Avenue, Palo Alto, CA 94304
-
Edited by James A. Wells, Sunesis Pharmaceuticals, Inc., Redwood City, CA, and approved March 6, 2001 (received for review December 20, 2000)
Abstract
Melanoma inhibitory activity (MIA) is a 12-kDa protein that is secreted from both chondrocytes and malignant melanoma cells. MIA has been reported to have effects on cell growth and adhesion, and it may play a role in melanoma metastasis and cartilage development. We report the 1.4-Å crystal structure of human MIA, which consists of an Src homology 3 (SH3)-like domain with N- and C-terminal extensions of about 20 aa each. The N- and C-terminal extensions add additional structural elements to the SH3 domain, forming a previously undescribed fold. MIA is a representative of a recently identified family of proteins and is the first structure of a secreted protein with an SH3 subdomain. The structure also suggests a likely protein interaction site and suggests that, unlike conventional SH3 domains, MIA does not recognize polyproline helices.
Footnotes
-
↵ ‡ To whom reprint requests should be addressed at: Department of Molecular and Cell Biology, Stanley/Donner ASU, 229 Stanley Hall No. 3206, University of California, Berkeley, CA 94720-3206. E-mail: handel{at}paradise1.berkeley.edu.
-
This paper was submitted directly (Track II) to the PNAS office.
-
Data deposition: The atomic coordinates have been deposited in the Protein Data Bank (PDB ID code 1I1J).
- Abbreviations:
- MIA,
- melanoma inhibitory activity;
- PPII,
- polyproline type II;
- SH3,
- Src homology 3
- Copyright © 2001, The National Academy of Sciences





